CRISPR Screen Dataset

Name: CRISPR SCREEN: Krall EB (2017) - 4-PMID28145866 (KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.)
Creator: BioGRID Project

Krall EB (2017) - 4-PMID28145866

H. sapiens

Title: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.

Screen Details:

Screen Type : Positive Selection | Format: Pool
Cell Line : NCI-H1299 cell | Type: Lung Cancer Cell Line (BTO)
Throughput : High Throughput
Enzyme : CAS9
Phenotype : Resistance To Chemicals
Experimental Setup : Drug Exposure | Duration: 21 Days | Condition Name: Trametinib (1.5 µM)
Library : GECKO v2 | Type: CRISPRn | Methodology: Knockout
Analysis Method : STARS | Number of Hits: 10 | Full Dataset Size: 20,703
Significance : Authors have indicated that results with Score.3 (FDR) < 0.1 are to be considered significant. These results are indicated by 'Yes' in the HIT column of the table below.

View More Screens from this Publication | Download Source Supplementary File

Score Distribution

< 12.4993174

> 0.30107916

CRISPR Screen Results (10 hits)

Download Screen

Advanced Filters